Literature DB >> 10714015

Combined thoracic aortic or upper digestive tract resection for lung cancer and malignant mediastinal tumor.

K Oyama1, T Onuki, M Mae, T Adachi, M Kanzaki, M Murasugi, Y Sone, J Kei, M Yokoyama, S Nitta.   

Abstract

OBJECTIVE: We studied possible indications and combined resection in patients with lung cancer and mediastinal tumors requiring combined thoracic aortic or upper digestive tract resection.
METHODS: Ten patients with lung cancer and malignant mediastinal tumors (9 men and 1 woman aged 39 to 72 years; mean: 60.5) underwent combined aortic or upper digestive tract resection.
RESULTS: Five--3 [corrected] with primary lung cancer, 1 with thymic cancer, and 1 with liposarcoma--, underwent combined aortic resection. In 2 each, lung cancer and malignant mediastinal tumor had infiltrated the thoracic aorta. The remaining case of lung cancer was complicated by aortic aneurysm in the distal arch. Cardiopulmonary bypass was conducted in 4, and selective cerebral perfusion in 2. Three patients are alive after 11, 22, and 61 months without disease recurrence. Those undergoing combined upper digestive tract resection all had lung cancer, with 4 having tumors infiltrating the esophagus or corpus ventriculi. The remaining patient had both lung and esophageal cancer. The patient treated with combined corpus ventriculi resection has survived 24 months and the patient treated with combined esophageal resection has survived 12 months without disease recurrence. The 1-year survival rate was 60%, 2-year 23%, and 3-year 23%. Prognosis was generally poor with the longest survival 13 months with N2 lung cancer.
CONCLUSIONS: In combined resection due to malignant mediastinal tumor, T4N0-1 lung cancer, or diseases such as aortic aneurysm, prognosis can be expected to improve. Despite the often poor prognosis in T4N2 lung cancer, surgical intervention may be indicated to avoid complications due to tumor invasion and to lengthen survival and improve quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 10714015     DOI: 10.1007/bf03218079

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  9 in total

1.  [Surgical treatment for lung cancer invading thoracic aorta].

Authors:  Y Saito; Y Yamakawa; H Niwa; M Kiriyama; I Fukai; Y Fujii
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-03

2.  Extended operation for lung cancer invading the aortic arch and superior vena cava.

Authors:  K Nakahara; K Ohno; A Mastumura; H Hirose; H Mastuda; S Nakano; R Shirakura; Y Kawashima
Journal:  J Thorac Cardiovasc Surg       Date:  1989-03       Impact factor: 5.209

3.  [Combined resection of the aorta for lung cancer invading the descending aorta].

Authors:  H Tokuda; M Waku; J Mori; A Koyama; H Anno; E Hata
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1988-06

4.  [A case of non-small-cell primary lung cancer invading distal aortic arch and left subclavian artery].

Authors:  K Tanaka; Y Murota; T Andoh; K Asano
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1995-11

5.  [Combined resection of the aortic wall in T4 lung cancer under the assistant devices].

Authors:  I Matsumoto; J Shimizu; M Oda; S Murakami; Y Uno; K Ietsugu; K Kobayashi; Y Ohtake; T Miyanaga; S Katada
Journal:  Kyobu Geka       Date:  1993-11

6.  Surgical treatment of cancer of the thoracic esophagus in association with a major pulmonary operation.

Authors:  T Matsubara; M Ueda; T Takahashi; T Nakajima; M Nishi
Journal:  J Am Coll Surg       Date:  1997-12       Impact factor: 6.113

7.  Extended resection of the left atrium, great vessels, or both for lung cancer.

Authors:  R Tsuchiya; H Asamura; H Kondo; T Goya; T Naruke
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

8.  Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer.

Authors:  P Macchiarini; A R Chapelier; I Monnet; J M Vannetzel; J L Rebischung; J Cerrina; F Parquin; F L Ladurie; B Lenot; P G Dartevelle
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

9.  Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.

Authors:  V W Rusch; K S Albain; J J Crowley; T W Rice; V Lonchyna; R McKenna; R B Livingston; B R Griffin; J R Benfield
Journal:  J Thorac Cardiovasc Surg       Date:  1993-01       Impact factor: 5.209

  9 in total
  3 in total

1.  Combined resection of distal aortic arch for T4N0 non-small-cell lung cancer with aortic arch invasion.

Authors:  M Chida; M Handa; G Yaginuma; H Suda; S Maeda; H Kazuma
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

2.  Complete resection of an anterior mediastinal tumor by total arch replacement and pulmonary artery trunk plasty with a pericardial patch: A case report.

Authors:  Yasuhiro Chikaishi; Hiroki Matsumiya; Masatoshi Kanayama; Akihiro Taira; Yusuke Nabe; Shinji Shinohara; Taiji Kuwata; Masaru Takenaka; Soichi Oka; Ayako Hirai; Koji Kuroda; Naoko Imanishi; Yoshinobu Ichiki; Yosuke Nishimura; Fumihiro Tanaka
Journal:  Ann Med Surg (Lond)       Date:  2018-09-25

3.  Direct Intraesophageal Growth from Metastatic Mediastinal Lymphadenopathy in Thymic Carcinoma.

Authors:  Hiroki Kanazawa; Nobukazu Sasaki; Takashi Kobayashi; Toshirou Fukushima; Shintaro Kanda; Tomonobu Koizumi; Mai Iwaya
Journal:  Intern Med       Date:  2020-10-21       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.